Filing Flows › Medicinova (MNOV) › Q1 2026
Medicinova (MNOV) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 14, 2026
Medicinova (MNOV) reported revenue of $187K for the first quarter 2026 (Q1 2026) and +23% from the quarter before.
Medicinova, Q1 2026: revenue $187K, net loss $2.6M, operating cash flow −$3.5M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $187K | +23% | — |
| Operating profit | −$2.8M | — | — |
| Net earnings | −$2.6M | — | — |
| Operating cash flow | −$3.5M | — | — |
What changed
Revenue was $187K in Q1 2026, up 23% from the previous quarter.
Operating costs exceeded revenue by $2.8M, an operating margin of -1516.6%. The quarter ended with a net loss of $2.6M, narrower than the previous quarter's $2.8M loss.
Operating cash flow was −$3.5M. Non-cash charges added back $4K of depreciation and amortization and $408K of share-based compensation. Working capital and other items used $1.3M. Capital expenditures of $11K exceeded it, leaving free cash flow of −$3.5M.
Questions
What was Medicinova's revenue in the first quarter 2026?
Medicinova (MNOV) reported revenue of $187K for the first quarter 2026 (Q1 2026) and +23% from the quarter before.
Source: Medicinova 10-Q on SEC EDGAR.